The interaction of bovine insulin with anti-human insulin antibody (mAb) was examined using a fluorescent probe. The fluorescence intensity of fluoresceinthiocarbamyl (FTC)-insulin was increased by adding mAb, and the increase was saturated at 53% at a molar ratio of FTC-insulin to mAb of 2.0. Based on the change in fluorescence intensity, a standard curve of the homogeneous competitive-type immunoassay was constructed, and the detection range of insulin was found to be 50-400 nM.
The specific interaction of antibody (Ab) with antigen (Ag) is used in immunoassay to provide quantitative determination of Ag concentration in an unknown sample.
1) Nowadays, sandwich immunoassays using enzymes or luminescent labels are widely used because of their high sensitivity and non-radioactivity although complicated and exhaustive washing processes are necessary.
2,3) Hence, simpler and highly sensitive immunoassays are desirable. In this study, we describe the Ab-Ag reaction between bovine insulin and mouse antihuman insulin monoclonal antibody (mAb) using insulin labeled with a fluorescent probe, fluorescein isothiocyanate (FITC), and its application to homogeneous competitive-type immunoassay.
Mouse anti-human insulin mAb (IgG1, Lot 9305P02) was purchased from Tosoh (Tokyo, Japan). Bovine insulin (Lot 901838) was from Biosys S.A. (Compiègne, France). Fluoresceinthiocarbamyl (FTC)-insulin was prepared by adding a 19.7-fold molar excess of FITC to insulin (48.2 M) in 50 mM borate buffer at pH 8.5 at 25 C and incubating the mixture for 5 h. The reaction was stopped by passing the mixture through a Sephadex G-15 column, and the FTC-insulin preparation was further purified with an anionic exchange HPLC column, Mono Q HR 5/5 [5 mm (inner diameter, ID) Â 50 mm] (Pharmacia, Uppsala, Sweden). The number (n) of amino groups modified was calculated by the following equation:
where 5,400 and 67,600 are molar absorption coefficients of insulin at 280 nm and FITC at 490 nm respectively, 4, 5) and 0.30 is the ratio of the absorption of FITC at 280 nm to that at 490 nm. Insulin containing 0.90 FTC group (mole/mole) was employed throughout the study. The purified preparation was incubated in 6 M HCl at 110 C for 3 h, followed by HPLC analysis using TSKgel ODS-80Ts [4.6 mm (ID) Â 150 mm]. FTC-Phe was detected in the analysis, indicating that the -amino group of the N-terminus of the insulin B-chain was modified by FITC. This result was in good agreement with the fact that the reactivity of the three amino groups of insulin was Phe (B1) > Gly (A1) ) Lys (B29).
6)
Emission spectra were observed on the mixing of FTC-insulin and mAb (Fig. 1) . The excitation and emission maxima were at 495 and 518 nm respectively. With the addition of mAb, fluorescence intensity increased without any change in the wavelength of the y To whom correspondence should be addressed. Tel: +81-75-753-6266; Fax: +81-75-753-6265; E-mail: inouye@kais.kyoto-u.ac.jp Abbreviations: FITC, fluorescein isothiocyanate; FTC, fluoresceinthiocarbamyl; mAb, monoclonal antibody; PBS, phosphate buffered saline emission maximum, and the increase in intensity was saturated at 53%, at a molar ratio of the FTC-insulin to mAb of 2.0 (Fig. 2) , indicating that this fluorescence change was due to the specific interaction between the FTC-insulin and mAb. The increase in intensity is perhaps derived from a change in the environment of the FTC group, namely, an increase in hydrophobicity and/ or a decrease in mobility of the FTC group. Assuming that the two Ag-binding sites of mAb are independent, the dissociation constant (K d ) is calculated from the change in fluorescence by the following equation:
where ÁF and ÁF max are the change in fluorescence intensity and the change observed when all the FTCinsulin molecules bind to mAb respectively, and [Ag] o and [Ab] o are the initial concentrations of Ag and the Ag-binding site respectively. The K d value was analyzed by Eq. 2 using non-linear least-squares regression.
7) The K d value was calculated to be 1:05 AE 1:01 nM. The standard deviation was fairly large, while the correlation for data fitting was rather high and the correlation coefficient (R) was 0.988. The change in fluorescence intensity observed in the interaction between FTCinsulin and mAb was applied to homogeneous competitive-type immunoassay. When the mixture of FTCinsulin and unlabeled insulin was mixed with mAb, the fluorescence intensity decreased with increases in the concentration of unlabeled insulin, indicating that FTCinsulin competed with unlabelled insulin for the limited amount of mAb. A standard curve was constructed based on the change in the fluorescence intensity observed using known concentrations of unlabeled insulin (Fig. 3) . The concentration of unlabelled insulin was calculated from the standard curve in the concentration range of 50-400 nM.
These observations suggest the possibility of a simple immunoassay without complicated procedures such as bound-free Ag (B/F) separation. The homogeneous immunoassay described above was performed with an ordinary spectrofluorophotometer. The insulin concentration in human serum is 0.05-0.2 nM. For practical use, it is necessary to optimize the conditions further depending on the concentration range of insulin to be detected. Improvement in the sensitivity of the detector, the number of FTC groups on the insulin molecule, the initial concentrations of FTC-insulin and mAb, the medium for fluorescence detection, and temperature is currently under way.
References 1) Johnstone, A., and Thorpe, R., Immunoassays. In ''Immunochemistry in Practice'' 3rd ed., Blackwell Science, Oxford, pp. 290-312 (1996) . 2) Inouye, K., and Morimoto, K., Preparation of Fðab 0 Þ 2 fragments of rat monoclonal antibodies (immunoglobulin M) and application of the fragments to the enzyme immunoassay of mouse interleukin-6. J. Immunol. Methods, 171, 239-244 (1994) . 3) Morimoto, K., and Inouye, K., A sensitive enzyme immunoassay of human thyroid-stimulating hormone (TSH) by using bispecific Fðab 0 Þ 2 fragments recognizing polymerized alkaline phosphatase and TSH. J. Immunol. Methods, 205, 81-90 (1997) . 4) Kinoshita, K., Maeda, H., and Hinuma, Y., Fluorescence polarization assay of plasmin, plasminogen, and plasminogen activator. Anal. Biochem., 104, 15-22 (1980). 5) Olsen, H. B., Ludvigsen, S., and Kaarsholm, N. C., Solution structure of an engineered insulin monomer at neutral pH. Biochemistry, 35, 8836-8845 (1996) . 6) Bromer, W. W., Sheehan, S. K., Berns, A. W., and 
